Sleep apnea devices help patients manage sleep-disordered breathing and maintain the airway. Continuous positive airway pressure (CPAP) devices are widely used to treat obstructive sleep apnea by gently blowing compressed air through a mask worn over the nose, mouth or both. This helps keep the airway open during sleep. The devices offer enhanced comfort, wireless connectivity capabilities and data tracking features to improve sleep quality and adherence to therapy.
The global Sleep Apnea Devices Market is estimated to be valued at US$ 5.8 billion in 2024 and is expected to exhibit a CAGR of 6.5% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The rising awareness about sleep disorders and availability of treatment options is a key trend driving the growth of the sleep apnea devices market. As per some recent studies, sleep apnea can increase the risks of diabetes, heart disease, and stroke. Therefore, more people are screening themselves for the condition and seeking treatment. A surge in diagnosed patient pool along with better diagnosis rates is supporting sales of CPAP machines and other sleep apnea management devices. Growing adoption of home healthcare has further accelerated demand as patients prefer non-invasive treatment from the comfort of their homes.
Segment Analysis
The global sleep apnea devices market can be segmented into diagnostic devices and therapeutic devices. Therapeutic devices is the dominating sub-segment, as continuous positive airway pressure (CPAP) devices form the first line of treatment for obstructive sleep apnea. CPAP devices continuously provide pressurized air through a mask that is placed on the face, to prevent throat collapse and breathing pauses during sleep.
Key Takeaways
The global sleep apnea devices market is expected to witness high growth. The global Sleep Apnea Devices Market is estimated to be valued at US$ 5.8 billion in 2024 and is expected to exhibit a CAGR of 6.5% over the forecast period 2023-2030.
The North America region currently dominates the global sleep apnea devices market. Higher awareness regarding sleep disorders and easy accessibility to diagnostic and treatment devices drive the North America market. The Asia Pacific region is expected to grow at the fastest pace during the forecast period. Increasing healthcare expenditure, growing geriatric population, and improving access to diagnosis and treatment in emerging countries are factors fueling the growth of the Asia Pacific sleep apnea devices market.
Key players
Key players operating in the sleep apnea devices are ResMed, Philips Respironics, Fisher & Paykel Healthcare, and BMC Medical. ResMed is the global market leader in non-invasive ventilation for medical applications such as obstructive sleep apnea, with a wide range of CPAP masks and devices available. Philips Respironics offers CPAP and BiPAP devices, as well as a line of therapeutic masks and interfaces. Fisher & Paykel Healthcare provides masks for various levels of sleep disordered breathing treatment including CPAP therapy masks.
No comments:
Post a Comment